The Nutrition Research Grant was established to further nutrition research in the Asia-Pacific region by providing funding support for research conducted in Asia-Pacific dsm-firmenich, innovators in nutrition, health, and beauty, will award a total of €250,000 through its inaugural Nutrition Research Grant to five distinguished researchers from the Asia-Pacific region.[Read More…]
Tag: dsm-firmenich
dsm-firmenich launches innovative multivitamin solution in Japan
This advanced protection ensures that vitamins retain their potency without compromising taste or texture dsm-firmenich, innovators in nutrition, health, and beauty, together with Rohto Pharmaceuticals announced the market launch in Japan of Vision R made with the dsm-firmenich patented Sprinkle It Technology (SIT™), multi-layered micronutrient granules designed to address nutritional insufficiencies amongst seniors in support[Read More…]
dsm-firmenich completes divestiture of Jiangshan Vitamin C plant in China
The production of vitamin C in Jiangshan was completely stopped in mid-May 2023 dsm-firmenich has recently sold its complete equity interest in DSM Jiangshan Pharmaceutical to Jingjiang Cosfocus Health Technology China. In June 2023, dsm-firmenich announced its plan to restructure its vitamin assets to reduce significant costs. As a part[Read More…]
EverSweet stevia sweetener receives safety opinions from EFSA and FSA
Avansya has quantified the sweetener’s environmental benefits through consecutive, third-party-verified life cycle assessments Avansya, the joint venture between Cargill and dsm-firmenich, announced that the EverSweet® stevia sweetener has received a positive safety opinion from both the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA), bringing the advanced sweetener one[Read More…]
dsm firmenich announces approval of HMO ingredients for infant nutrition in Australia and New Zealand
dsm-firmenich is the first HMO manufacturer to apply and obtain approval for the four HMOs in this region dsm-firmenich, a leading innovator in health, nutrition and beauty, announced that it has gained approval for an additional four human milk oligosaccharide (HMO) ingredients for use as nutritive substances in infant formula products in[Read More…]
dsm-firmenich announces Peach+ as 12th annual flavour of Year for 2024
Peach+ was inspired by PANTONE 13-1023 Peach Fuzz, the 2024 Colour of the Year from PANTONE dsm-firmenich, an innovator in nutrition, health, and beauty, announces Peach+ as the 12th annual “Flavor of the Year” for 2024. Peach+ was inspired by PANTONE 13-1023 Peach Fuzz, the 2024 Colour of the Year from PANTONE, the global colour authority and provider[Read More…]
dsm-firmenich and Boncha Bio partners to advance nutraceuticals with candy-capsule technology in Asia
The partnership aims to redefine the dietary supplement landscape by introducing market-ready candyceuticals that meld sensory delight with health benefits In a landmark development, Boncha Bio is elated to announce a strategic partnership in Asia with dsm-firmenich, a global innovator in nutrition, health, and beauty. This groundbreaking partnership was ceremoniously inked on September 21st at[Read More…]
Indena dsm-firmenich announce strategic partnership for botanical solutions
This cooperation will bring highly effective Market-ready Solutions to the market and, in the medium- and long-term, products that will be new in terms of their origin, ingredient combination and formulation Indena, a private Italian company and dsm-firmenich, innovators in nutrition, health and beauty, have announced a strategic partnership in[Read More…]
dsm-firmenich achieves regulatory clearance in China for HMO ingredients
The two HMOs that received approval in China include GlyCare 2’-fucosyllactose (2’-FL), the most prevalent HMO in human breast milk, and GlyCare lacto-N-neotetraose (LNnT) dsm-firmenich, the leading innovator in health, nutrition and beauty, announced that two of its human milk oligosaccharide (HMO) ingredients have been approved as fortifiers for infant[Read More…]
